Recent Developments On Activatable Turn‐On Fluorogenic Donors of Hydrogen Sulfide (H2S)

Abstract

AbstractHydrogen sulfide (H2S) is considered the third member of the gasotransmitter family, along with nitric oxide (NO) and carbon monoxide (CO). Besides its role in physiological and pathophysiological conditions, the promising therapeutic potential of this small‐molecule makes it advantageous for various pharmaceutical applications. The endogenous production of H2S at a lower concentration is crucial in maintaining redox balance and cellular homeostasis, and the dysregulation leads to various disease states. In the event of H2S deficiency, the exogenous donation of H2S could help maintain the optimal cellular concentration of H2S and cellular homeostasis. Over the last several years, researchers have developed numerous small‐molecule non‐fluorogenic organosulfur compounds as H2S donors and investigated their pharmacological potentials. However, reports on stimuli‐responsive turn‐on fluorogenic donors of H2S have appeared recently. Interestingly, the fluorogenic H2S donors offer additional advantages with the non‐invasive real‐time monitoring of the H2S release utilizing the simultaneous turn‐on fluorogenic processes. The review summarizes the recent developments in turn‐on fluorogenic donors of H2S and the potential biological applications that have developed over the years.